Search results for DNMT3A antibody

Anti-Dnmt3a antibody, Abcam, AB226261

Anti-Dnmt3a antibody, Abcam, AB2850

Anti-DNMT3A Antibody (R2L30), AntibodySystem, RHJ91402

Anti-DNMT3A Antibody (R3X83), AntibodySystem, RHJ91403

Anti-Dnmt3a antibody [EPR18455], Abcam, AB188470

What is this antibody validated in? Anti-Dnmt3a antibody [EPR18455] (ab188470) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples. What is the molecular weight of Dnmt3a? Anti-Dnmt3a [EPR18455] (ab188470) specifically detects a band for Dnmt3a (UniProt: Q9Y6K1) at a molecular weight of 102kDa. Trusted by the scientific community Anti-Dnmt3a [EPR18455] (ab188470) was first used in a scientific publication in 2015 and has been cited over 30 times in peer-reviewed journals. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Specificity confirmed The specificity of Anti-Dnmt3a antibody [EPR18455] (ab188470) has been confirmed by Western blot testing in DNMT3A Knockout HAP1 cell line, ab261793 . Other related products We have a range of other formats of antibody clone [EPR18455] also available for your convenience: ab188470, Carrier free - ab232391 , Carrier free - ab300008, PE - ab305716 , APC - ab305717 , HRP - ab305718 , Alkaline Phosphatase - ab308817 , Alexa Fluor® 488 - ab309762 , Alexa Fluor® 647 - ab310130 , Alexa Fluor® 594 - ab310548 , Alexa Fluor® 555 - ab312078 , Alexa Fluor® 568 - ab312555 , Alexa Fluor® 750 - ab321309 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

HRP Anti-Dnmt3a antibody [EPR18455], Abcam, AB305718

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-Dnmt3a antibody [EPR18455], Abcam, AB305716

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

DNMT3A Antibody (YA4603)(PBS only), MedChemexpress, HY-P84906A

DNMT3A Antibody (YA4603) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to DNMT3A.

DNMT3A antibody [PCRP-DNMT3A-1E2], Genetex, GTX18052

DNMT3A Antibody Sampler Kit#93140, Cell Signaling Technology (CST), 93140